Danone S.A. BN.PA
Composite 45/100; the shares have moved about 23% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 26/100 — a moderate mark against it.
Income ranks 74/100 — a moderate point in its favour. Valuation ranks 66/100 — a moderate point in its favour.
Growth ranks 26/100 — a moderate mark against it. Momentum ranks 30/100 — a moderate mark against it. Quality ranks 43/100 — a slight mark against it.
What the company does Danone S.A. (BN.PA) is a global food and beverage company with three segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Its brands include Actimel, Activia, Alpro, evian, Nutricia, and Silk, spanning yogurts, plant-based products, baby nutrition, and mineral waters across 50+ countries.
Key financials Danone’s profitability metrics show mixed signals: ROE 11%, ROA 5%, ROCE 22%, gross margin 51%, operating margin 14%, net margin 7%. Revenue fell -0.5% and EPS -2.5% year-over-year. Leverage is moderate (Debt/Equity 1.0), but interest coverage is 5x and net debt/EBITDA 2.0x.
Stock health The stock exhibits low volatility (beta 0.19) and weak momentum: -4.3% over 1 day, -4.3% over 12 months, and -12.8% below its 52-week high. SIDERAVIA scores it average overall (53/100), with strong income (76/100) but weak growth (32/100).
Price vs fair value Danone trades at a PREMIUM of 6.20% to our fair-value estimate of 63.33 and a discount of 18.52% to the 12-month analyst target of 80.02. - Recent sales growth in Asia is cited as a driver of optimism (The Wall Street Journal). - H1 2026 earnings call highlighted “strong sales growth and strategic expansions” (GuruFocus.com). - Comparisons to competitors frame Danone as a value play (Zacks).
Looking forward Forward P/E of 18x and PEG of 0.47 suggest undemanding valuation versus long-term growth, while dividend yield is 3.2% with a 75% payout ratio. Analysts (n=21) see 18% upside to 80.02 over 12 months, balancing near-term premium to fair value with longer-term potential.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.